Annual direct medical costs associated with diabetes‐related complications in the event year and in subsequent years in Hong Kong

To develop models to estimate the direct medical costs associated with diabetes‐related complications in the event year and in subsequent years.

[1]  S. Tang,et al.  Health-related quality of life and health preference of Chinese patients with diabetes mellitus managed in primary care and secondary care setting: decrements associated with individual complication and number of complications , 2017, Health and Quality of Life Outcomes.

[2]  S. McGhee,et al.  Long-term effects of the multidisciplinary risk assessment and management program for patients with diabetes mellitus (RAMP-DM): a population-based cohort study , 2015, Cardiovascular Diabetology.

[3]  C. Lam,et al.  Patient Empowerment Programme (PEP) and Risk of Microvascular Diseases Among Patients With Type 2 Diabetes in Primary Care: A Population-Based Propensity-Matched Cohort Study , 2015, Diabetes Care.

[4]  A Gray,et al.  The impact of diabetes‐related complications on healthcare costs: new results from the UKPDS (UKPDS 84) , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[5]  C. Lam,et al.  Patient Empowerment Programme in primary care reduced all‐cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population‐based propensity‐matched cohort study , 2015, Diabetes, obesity & metabolism.

[6]  A. Esteghamati,et al.  The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus , 2014, Journal of Diabetes & Metabolic Disorders.

[7]  K. Chow,et al.  Prevalence of complications among Chinese diabetic patients in urban primary care clinics: a cross-sectional study , 2014, BMC Family Practice.

[8]  G. Glaeske,et al.  Impact of diabetes on costs before and after major lower extremity amputations in Germany. , 2013, Journal of diabetes and its complications.

[9]  P. Wong,et al.  Hong Kong Renal Registry Report 2012 , 2013 .

[10]  Eva L. H. Tsui,et al.  Evaluation of the quality of care of a multi-disciplinary risk factor assessment and management programme (RAMP) for diabetic patients , 2012, BMC Family Practice.

[11]  Young Seol Kim,et al.  Direct Medical Costs for Patients with Type 2 Diabetes and Related Complications: A Prospective Cohort Study Based on the Korean National Diabetes Program , 2012, Journal of Korean medical science.

[12]  M. Javanbakht,et al.  Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran , 2011, PloS one.

[13]  James R Christina,et al.  The economic value of specialized lower-extremity medical care by podiatric physicians in the treatment of diabetic foot ulcers. , 2011, Journal of the American Podiatric Medical Association.

[14]  Biao Xu,et al.  Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital based survey in urban China , 2010, Health and quality of life outcomes.

[15]  V. Lee,et al.  Cost of Type 2 Diabetes mellitus in Hong Kong Chinese. , 2007, International journal of clinical pharmacology and therapeutics.

[16]  Zhiqiang Wang,et al.  Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. , 2006, Diabetes research and clinical practice.

[17]  C. Alexander,et al.  End-stage renal disease-associated managed care costs among patients with and without diabetes. , 2004, Diabetes care.

[18]  Morton B. Brown,et al.  The direct medical cost of type 2 diabetes. , 2003, Diabetes care.

[19]  R Legood,et al.  The impact of diabetes‐related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65) , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[20]  T. Lam,et al.  The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community‐based population study in Hong Kong Chinese , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[21]  M. Knapp,et al.  Client Socio-Demographic and Service Receipt Inventory – European Version: development of an instrument for international research , 2000, British Journal of Psychiatry.

[22]  E. Wagner,et al.  Patient-Level Estimates of the Cost of Complications in Diabetes in a Managed-Care Population , 1999, PharmacoEconomics.

[23]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[24]  Uk-Prospective-Diabetes-Study-Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[25]  J. O'brien,et al.  Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie U.S. , 1998, Diabetes Care.

[26]  C. Agardh,et al.  Long‐term prognosis for diabetic patients with foot ulcers , 1993, Journal of internal medicine.

[27]  A. Icks,et al.  Long-Term Prognosis of Diabetic Foot Patients and Their Limbs Amputation and death over the course of a decade , 2012 .

[28]  G. Duvel.  The study group. , 1980 .